Recognition of the Importance of Embolization in Atherosclerotic Vascular Disease

Risk Factors of Cardiac Troponin T Elevation in Patients with Stable Coronary Artery Disease After Elective Coronary Drug‐Eluting Stent Implantation

“…This supports that cardiac troponin T elevation was quite common after PCI in patients with stable CAD. The mechanisms responsible for cardiac enzyme release after PCI were related to myocardial ischemic injury or necrosis, caused by occlusion due to embolization, 14,15 side branch occlusion due to plaque shifting, 16,17 coronary dissection, 18 coronary spasm, 16 hypotension requiring administration of vasopressors, 19 and prolonged ischemia due to balloon inflations. 20 There were few studies comprehensively elaborating the risk factors of troponin T elevation after PCI in patients with stable CAD.…”

<b>Percutaneous Coronary Arterial Thrombectomy for Acute Myocardial Infarction Reduces No-Reflow Phenomenon and Protects Against Left Ventricular Remodeling Related to the Proximal Left Anterior Descending and Right Coronary Artery</b>

“…14,36,40,41) We believe that these other causes contributed to the controversial results of previous thrombectomy studies. 13,14,36,40,42) Fifth, GP IIb/IIIa inhibitors or abciximab are not available in Japan, and therefore the results of this study will not be considered to be world-standard of care during PCI. However, we feel that our results are useful for the treatment of patients in Japan.…”

Comparison of rheolytic thrombectomy before direct infarct artery stenting versus direct stenting alone in patients undergoing percutaneous coronary intervention for acute myocardial infarction

“…1 In the setting of acute myocardial infarction (AMI), PCI-related embolization results in a decreased efficacy of mechanical reperfusion and myocardial salvage. Direct stenting without predilation may decrease embolization and the incidence of the no-reflow phenomenon.…”